IP Library Granted Patent US 10,465,185
Granted Patent B1
US 10,465,185 · App. 16/423,289 · Granted Nov 5, 2019

Automated cell processing methods, modules, instruments, and systems

Inventors: Don Masquelier (Boulder, CO); Phillip Belgrader (Pleasanton, CA); Jorge Bernate (Boulder, CO); Ryan Gill (Boulder, CO); Kevin Ness (Boulder, CO)
Assignee: Inscripta, Inc.
C12N15/1082C12M23/44C12M33/14C12M35/00C12M37/04C12M41/36C12M41/48C12M43/00C12N9/22C12N15/11C40B40/02C12N2310/20C12N2800/80
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,465,185
App. No.
16/423,289
Granted
Nov 5, 2019
Kind
B1
Abstract

In an illustrative embodiment, automated multi-module cell editing instruments are provided to automate multiple edits into nucleic acid sequences inside one or more cells.

Claims (32)

1. A method of creating a cell library of at least 5,000 edited cells using an automated stand-alone multi-module cell editing instrument for nuclease-directed genome editing, comprising the steps of:

providing live cells in a receptacle configured to receive cells;

providing a library of rationally-designed nucleic acids comprising sequences to facilitate nuclease-directed genome edits in the cells in a receptacle configured to receive nucleic acids;

growing the live cells in a growth module;

transforming the live cells in a transformation module with the library of rationally-designed nucleic acids;

providing conditions in a nuclease-directed editing module to allow nuclease-directed editing of nucleic acids in the cells; and

using an automated liquid handling system to move liquids from the receptacle configured to receive the cells to the growth module, from the growth module to the transformation module, from the receptacle configured to receive the rationally-designed nucleic acids to the transformation module, and from the transformation module to the nuclease-directed editing module without user intervention, wherein the nuclease-directed genome edits created in the automated stand-alone multi-module cell editing instrument result in a cell library comprising at least 5,000 cells with rationally-designed genome edits.

2. The method of claim 1 , wherein the rationally-designed genome edits in the cells create a saturation mutagenesis cell library.

3. The method of claim 1 , wherein the rationally-designed genome edits in the cells create a promoter swap cell library.

4. The method of claim 1 , wherein the rationally-designed genome edits in the cells create a terminator swap cell library.

5. The method of claim 1 , wherein the rationally-designed genome edits in the cells create a SNP swap cell library.

6. The method of claim 1 , wherein the rationally-designed genome edits in the cells create a promoter and terminator swap cell library.

7. The method of claim 1 , wherein the library comprises at least 100,000 edited cells.

8. The method of claim 7 , wherein the library comprises at least 1,000,000 edited cells.

9. The method of claim 1 , wherein the nuclease-directed genome editing is CRISPR-directed genome editing.

10. The method of claim 1 , wherein the nuclease-directed genome editing is TALEN-directed genome editing.

11. The method of claim 1 , wherein the automated liquid handling system moves the cell library comprising individual cells with rationally-designed genome edits from the nuclease-directed editing module to the growth module.

12. A method of creating a cell library of at least 5,000 cells using an automated stand-alone multi-module cell editing instrument for nuclease-directed genome editing, comprising the steps of:

providing a cell receptacle configured to receive cells;

providing a nucleic acid receptacle configured to receive rationally-designed nucleic acids comprising sequences to facilitate nuclease-directed genome editing events in the cells;

filtering the cells in a filtration module configured to render the cells electrocompetent;

transforming the electrocompetent cells in a transformation module configured to introduce the rationally-designed nucleic acids into the cells;

providing conditions in a nuclease-directed editing module to allow nuclease-directed editing of nucleic acids in the cells; and

using an automated liquid handling system to move liquids from the receptacle configured to receive cells to the filtration module, from the filtration module to the transformation module, from the receptacle configured to receive rationally-designed nucleic acids to the transformation module, and from the transformation module to the nuclease-directed editing module without user intervention, wherein the nuclease-directed genome edits created in the automated stand-alone multi-module cell editing instrument result in a cell library comprising at least 5,000 cells with rationally-designed genome edits.

13. The method of claim 12 , wherein the rationally-designed genome edits in the cells create a saturation mutagenesis cell library.

14. The method of claim 12 , wherein the rationally-designed genome edits in the cells create a promoter swap cell library.

15. The method of claim 12 , wherein the rationally-designed genome edits in the cells create a terminator swap cell library.

16. The method of claim 12 , wherein the rationally-designed genome edits in the cells create a SNP swap cell library.

17. The method of claim 12 , wherein the rationally-designed genome edits in the cells create a promoter and terminator swap cell library.

18. The method of claim 12 , wherein the library comprises at least 100,000 edited cells.

19. The method of claim 18 , wherein the library comprises at least 1,000,000 edited cells.

20. The method of claim 12 , wherein the nuclease-directed genome editing is CRISPR-directed genome editing.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 28, 2019
From: MASQUELIER, DON; BELGRADER, PHILLIP; BERNATE, JORGE; GILL, RYAN; NESS, KEVIN
To: INSCRIPTA, INC.
Reel/Frame 049289/0614 →
Continuity (15)
Continuation 16269655 · Feb 7, 2019
Continuation 16024816 · Jun 30, 2018
Provisional Application 62527339 · Jun 30, 2017
Provisional Application 62551069 · Aug 28, 2017
Provisional Application 62566374 · Sep 30, 2017
Provisional Application 62566375 · Sep 30, 2017
Provisional Application 62566688 · Oct 2, 2017
Provisional Application 62567697 · Oct 3, 2017
Provisional Application 62620370 · Jan 22, 2018
Provisional Application 62649731 · Mar 29, 2018
Provisional Application 62671385 · May 14, 2018
Provisional Application 62648130 · Mar 26, 2018
Provisional Application 62657651 · Apr 13, 2018
Provisional Application 62657654 · Apr 13, 2018
Provisional Application 62689068 · Jun 23, 2018